バイオ医薬品添加剤の市場規模、シェア、成長分析：製品別、機能別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

バイオ医薬品添加剤の世界市場規模は2023年に23億米ドルと評価され、予測期間（2025-2032年）のCAGRは5.6%で、2024年の24億3,000万米ドルから2032年には37億6,000万米ドルに成長する見通しです。

2023年10月現在、世界のバイオ医薬品添加剤市場は、バイオ医薬品需要の増加、個別化医療へのシフト、バイオテクノロジーとドラッグデリバリーシステムの革新に後押しされ、安定した上昇基調にあります。がんや自己免疫疾患のような慢性疾患の有病率の増加により、より少ない副作用で患者の予後を改善する標的療法の必要性が高まっています。さらに、従来の低分子医薬品よりも生物学的製剤が好まれる傾向が顕著であり、バイオテクノロジーの進歩も相まって、これらの革新的な治療法に合わせた特殊な賦形剤の需要が高まっています。しかし、市場は複雑な規制環境、高度な製造要件による高い運用コスト、従来のものと比べて高いバイオ医薬品添加剤の価格などの課題に直面しており、より広範な採用の妨げとなっている可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バイオ医薬品添加剤市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 炭水化物
  • デキストロース
  • スターチ
  • スクロース
• ポリオール
  • マンニトール
  • ソルビトール
• 可溶化剤および界面活性剤/乳化剤
  • エステル
  • トリグリセリド
• 特殊添加剤

バイオ医薬品添加剤市場規模：機能別& CAGR（2025-2032）

• 市場概要
• バインダー
• コーティング
• 崩壊剤
• 潤滑剤と滑剤
• 医薬品充填剤
• 防腐剤

バイオ医薬品添加剤市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 高度な伝送システム
• 経口
• 非経口
• 外用

バイオ医薬品添加剤市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 契約製造組織
• 製薬・バイオテクノロジー企業

バイオ医薬品添加剤市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Merck KGaA（Germany）
• BASF SE（Germany）
• Evonik Industries AG（Germany）
• Roquette Freres（France）
• Colorcon, Inc.（USA）
• DFE Pharma（Germany）
• Avantor, Inc.（USA）
• Kerry Group plc（Ireland）
• Associated British Foods plc（UK）
• Wacker Chemie AG（Germany）
• Lubrizol Corporation（USA）
• J. Rettenmaier & Sohne GmbH+Co KG（Germany）
• SPI Pharma（USA）
• Fuji Chemical Industries Co., Ltd.（Japan）
• Meggle GmbH & Co. KG（Germany）
• Beneo GmbH（Germany）

結論と推奨事項

Global Biopharmaceuticals Excipients Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.43 billion in 2024 to USD 3.76 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

As of October 2023, the global biopharmaceutical excipients market is on a steady upward trajectory, fueled by rising demand for biopharmaceutical drugs, a shift towards personalized medicine, and innovations in biotechnology and drug delivery systems. The increasing prevalence of chronic conditions like cancer and autoimmune disorders has heightened the need for targeted therapies, enhancing patient outcomes with fewer side effects. Furthermore, there is a notable preference for biologics over traditional small-molecule drugs, coupled with ongoing biotechnological advancements that drive the demand for specialized excipients tailored for these innovative therapies. However, the market faces challenges including a complex regulatory environment, high operational costs due to advanced manufacturing requirements, and the elevated price of biopharmaceutical excipients compared to their conventional counterparts, potentially hindering broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Excipients Market Segmental Analysis

Global Biopharmaceuticals Excipients Market is segmented by Product, Function, Application, End User and region. Based on Product, the market is segmented into Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers and Specialty Excipients. Based on Function, the market is segmented into Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers and Preservatives. Based on Application, the market is segmented into Advanced Delivery System, Oral, Parenteral and Topical. Based on End User, the market is segmented into Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market is being significantly driven by the escalating demand for biopharmaceuticals, primarily fueled by the rising incidence of chronic diseases and an aging population. As more individuals seek effective therapeutic solutions, the preference for biologics has intensified due to their targeted approach and enhanced efficacy. This shift necessitates the incorporation of specialized excipients that improve drug attributes such as stability, solubility, and delivery mechanisms. Consequently, the continuous innovation and adaptation of excipients tailored for biopharmaceutical applications are vital in meeting the evolving requirements of the pharmaceutical industry, thereby fostering market growth.

Restraints in the Global Biopharmaceuticals Excipients Market

The global biopharmaceutical excipients market faces significant challenges due to a complex regulatory landscape. The stringent and intricate approval processes for biopharmaceutical drugs require extensive testing and validation of excipients utilized in biologic formulations. This complexity compels excipient manufacturers to navigate a multitude of regulatory standards, which can be time-consuming and resource-intensive. As a result, these regulatory hurdles may impede the growth and expansion of the market, making it difficult for manufacturers to introduce new products and adapt to evolving compliance demands. Consequently, the intricate nature of regulatory requirements presents a substantial restraint on the biopharmaceutical excipients market.

Market Trends of the Global Biopharmaceuticals Excipients Market

The global biopharmaceuticals excipients market is witnessing a significant trend driven by the increasing demand for specialty and functional excipients. As biologic drugs evolve and expand in complexity, the need for excipients that cater to specific formulation requirements has surged. These specialty excipients, designed for functionalities such as protein stabilization, controlled drug release, and enhanced solubility, are gaining traction among manufacturers striving to optimize therapeutic efficacy and patient outcomes. This shift not only underscores the pivotal role of excipients in drug development but also reflects the biopharmaceutical industry's commitment to innovation and precision in delivering advanced healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biopharmaceuticals Excipients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Carbohydrates
  • Dextrose
  • Starch
  • Sucrose
• Polyols
  • Mannitol
  • Sorbitol
• Solubilizers & Surfactants/Emulsifiers
  • Esters
  • Triglycerides
• Specialty Excipients

Global Biopharmaceuticals Excipients Market Size by Function & CAGR (2025-2032)

• Market Overview
• Binders
• Coatings
• Disintegrants
• Lubricants & glidants
• Pharmaceutical Fillers
• Preservatives

Global Biopharmaceuticals Excipients Market Size by Application & CAGR (2025-2032)

• Market Overview
• Advanced Delivery System
• Oral
• Parenteral
• Topical

Global Biopharmaceuticals Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Contract Manufacturing Organizations
• Pharmaceutical & Biotechnology Companies

Global Biopharmaceuticals Excipients Market Size & CAGR (2025-2032)

• North America (Product, Function, Application, End User)
  • US
  • Canada
• Europe (Product, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lubrizol Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Rettenmaier & Sohne GmbH + Co KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meggle GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beneo GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations